SCHEMBL4904415

SCHEMBL4904415

CCN(Oc1ccc(C(C)(C)C)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
TSHR P16473 2/20 0.40
MMP9 P14780 1/20 0.39
MMP13 P45452 1/20 0.39
NR1I2 O75469 3/20 0.37
HSD17B10 Q99714 2/20 0.35
RECQL P46063 2/20 0.35
LMNA P02545 1/20 0.35
ALOX15 P16050 1/20 0.35
APEX1 P27695 1/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
HCRTR2 O43614 1/20 0.35
KDM4E B2RXH2 1/20 0.34
HIF1A Q16665 1/20 0.34
TP53 P04637 1/20 0.34
HDAC3 O15379 1/20 0.33
HDAC11 Q96DB2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903874 0.91 ALDH1A1 (0.39) ALDH1A1TSHRMMP9MMP13LMNA
SCHEMBL4908598 0.89 MMP9 (0.38) ALDH1A1MMP9MMP13HSD17B10LMNA
SCHEMBL4902618 0.88 ALDH1A1 (0.46) ALDH1A1TSHRMMP9MMP13NR1I2
SCHEMBL4901791 0.88 ALDH1A1 (0.42) ALDH1A1TSHRMMP9HSD17B10LMNA
SCHEMBL4906234 0.84 ALDH1A1 (0.46) ALDH1A1TSHRMMP9MMP13NR1I2
SCHEMBL4906634 0.81 ALDH1A1 (0.40) ALDH1A1TSHRMMP9MMP13NR1I2
SCHEMBL4901009 0.80 HDAC8 (0.37) ALDH1A1HSD17B10LMNAKDM4EHDAC8
SCHEMBL4906110 0.80 POLB (0.43) ALDH1A1TSHRMMP9MMP13HSD17B10
SCHEMBL4904268 0.78 HCRTR2 (0.41) ALDH1A1LMNAMAPK1HCRTR2KDM4E
SCHEMBL4906931 0.75 PTPN5 (0.38) ALDH1A1TSHRMMP9MMP13HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885MMP9 4666/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885MMP9 4632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.